Concepts (295)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 15 | 2026 | 260 | 6.890 |
Why?
|
| Stress Disorders, Post-Traumatic | 33 | 2026 | 407 | 5.110 |
Why?
|
| Microbiota | 7 | 2025 | 165 | 3.900 |
Why?
|
| Alzheimer Disease | 8 | 2026 | 770 | 2.870 |
Why?
|
| Dysbiosis | 7 | 2024 | 74 | 2.710 |
Why?
|
| Frailty | 4 | 2022 | 129 | 2.280 |
Why?
|
| Feces | 6 | 2024 | 117 | 2.240 |
Why?
|
| Anti-Bacterial Agents | 8 | 2022 | 821 | 1.850 |
Why?
|
| Emergency Service, Hospital | 17 | 2026 | 1145 | 1.830 |
Why?
|
| Soft Tissue Infections | 4 | 2020 | 48 | 1.620 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2020 | 96 | 1.590 |
Why?
|
| Asymptomatic Infections | 2 | 2025 | 29 | 1.560 |
Why?
|
| Cognitive Dysfunction | 4 | 2026 | 351 | 1.550 |
Why?
|
| Bacteria | 6 | 2026 | 338 | 1.550 |
Why?
|
| Urinary Tract Infections | 2 | 2025 | 96 | 1.540 |
Why?
|
| Nursing Homes | 6 | 2024 | 675 | 1.260 |
Why?
|
| Aging | 3 | 2026 | 766 | 1.160 |
Why?
|
| Clostridium Infections | 2 | 2021 | 49 | 1.140 |
Why?
|
| Aged | 29 | 2026 | 14958 | 1.130 |
Why?
|
| Metagenomics | 3 | 2024 | 30 | 1.080 |
Why?
|
| Humans | 80 | 2026 | 65554 | 1.040 |
Why?
|
| Male | 49 | 2026 | 31083 | 1.000 |
Why?
|
| Female | 51 | 2026 | 34131 | 0.970 |
Why?
|
| Urine | 1 | 2025 | 45 | 0.910 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2016 | 34 | 0.910 |
Why?
|
| Diarrhea | 2 | 2016 | 76 | 0.890 |
Why?
|
| Pneumonia, Bacterial | 2 | 2018 | 90 | 0.890 |
Why?
|
| Middle Aged | 37 | 2026 | 18277 | 0.850 |
Why?
|
| Inflammation | 5 | 2026 | 1186 | 0.840 |
Why?
|
| Adult | 41 | 2026 | 17417 | 0.830 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 174 | 0.820 |
Why?
|
| Weevils | 1 | 2023 | 1 | 0.820 |
Why?
|
| Prospective Studies | 17 | 2026 | 3355 | 0.820 |
Why?
|
| Cognition | 3 | 2026 | 502 | 0.810 |
Why?
|
| Influenza, Human | 3 | 2014 | 212 | 0.750 |
Why?
|
| Guideline Adherence | 3 | 2020 | 315 | 0.730 |
Why?
|
| Aged, 80 and over | 11 | 2026 | 5620 | 0.710 |
Why?
|
| Treatment Failure | 3 | 2021 | 208 | 0.680 |
Why?
|
| Young Adult | 23 | 2026 | 4831 | 0.640 |
Why?
|
| Fear | 3 | 2025 | 71 | 0.620 |
Why?
|
| Skin Diseases, Infectious | 2 | 2016 | 12 | 0.610 |
Why?
|
| Polysaccharides | 1 | 2021 | 154 | 0.600 |
Why?
|
| Longitudinal Studies | 14 | 2026 | 1287 | 0.600 |
Why?
|
| Inappropriate Prescribing | 1 | 2020 | 68 | 0.600 |
Why?
|
| White Matter | 3 | 2025 | 125 | 0.590 |
Why?
|
| Survivors | 5 | 2026 | 184 | 0.570 |
Why?
|
| Biomarkers | 7 | 2026 | 1473 | 0.560 |
Why?
|
| Macrolides | 1 | 2018 | 38 | 0.550 |
Why?
|
| Alcohol Drinking | 3 | 2025 | 322 | 0.550 |
Why?
|
| Antacids | 1 | 2017 | 14 | 0.540 |
Why?
|
| Community-Acquired Infections | 1 | 2018 | 94 | 0.530 |
Why?
|
| Independent Living | 1 | 2017 | 55 | 0.520 |
Why?
|
| Nutritional Status | 1 | 2017 | 99 | 0.520 |
Why?
|
| Bacterial Infections | 2 | 2023 | 154 | 0.510 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 801 | 0.510 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2025 | 2248 | 0.510 |
Why?
|
| Wounds and Injuries | 3 | 2026 | 261 | 0.490 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 182 | 0.480 |
Why?
|
| Cohort Studies | 9 | 2025 | 2632 | 0.470 |
Why?
|
| Cytokines | 2 | 2026 | 956 | 0.470 |
Why?
|
| Psychological Trauma | 3 | 2026 | 23 | 0.470 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2015 | 9 | 0.470 |
Why?
|
| Outpatients | 1 | 2016 | 142 | 0.460 |
Why?
|
| Tobacco Use | 2 | 2025 | 42 | 0.450 |
Why?
|
| Marijuana Use | 2 | 2025 | 22 | 0.440 |
Why?
|
| Mediator Complex | 1 | 2014 | 13 | 0.440 |
Why?
|
| Hyphae | 1 | 2014 | 18 | 0.440 |
Why?
|
| Health Personnel | 3 | 2025 | 393 | 0.430 |
Why?
|
| Hemagglutinins, Viral | 1 | 2014 | 12 | 0.430 |
Why?
|
| Resilience, Psychological | 2 | 2026 | 67 | 0.430 |
Why?
|
| Neoplasms | 1 | 2025 | 1415 | 0.430 |
Why?
|
| Administration, Intravenous | 1 | 2014 | 68 | 0.420 |
Why?
|
| Candida albicans | 1 | 2014 | 75 | 0.420 |
Why?
|
| RNA, Ribosomal, 16S | 4 | 2023 | 106 | 0.420 |
Why?
|
| Reward | 2 | 2024 | 89 | 0.420 |
Why?
|
| Fungal Proteins | 1 | 2014 | 152 | 0.410 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2026 | 95 | 0.410 |
Why?
|
| Smartphone | 2 | 2026 | 72 | 0.410 |
Why?
|
| Antibodies, Viral | 2 | 2023 | 325 | 0.410 |
Why?
|
| Residence Characteristics | 2 | 2026 | 234 | 0.410 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 90 | 0.400 |
Why?
|
| Wearable Electronic Devices | 2 | 2024 | 76 | 0.380 |
Why?
|
| Heart Rate | 2 | 2024 | 331 | 0.380 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2026 | 91 | 0.370 |
Why?
|
| Accidents, Traffic | 6 | 2022 | 146 | 0.360 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 167 | 0.350 |
Why?
|
| Virus Diseases | 1 | 2012 | 120 | 0.350 |
Why?
|
| Machine Learning | 3 | 2024 | 195 | 0.350 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2022 | 716 | 0.340 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 1575 | 0.310 |
Why?
|
| Amygdala | 3 | 2024 | 85 | 0.310 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2025 | 73 | 0.300 |
Why?
|
| Prefrontal Cortex | 3 | 2024 | 126 | 0.300 |
Why?
|
| Risk Factors | 8 | 2025 | 5441 | 0.300 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 739 | 0.290 |
Why?
|
| Wrist | 3 | 2024 | 39 | 0.290 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2026 | 42 | 0.290 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2014 | 92 | 0.290 |
Why?
|
| Depression | 7 | 2023 | 916 | 0.280 |
Why?
|
| Pain | 3 | 2023 | 403 | 0.280 |
Why?
|
| Brain | 7 | 2024 | 1606 | 0.270 |
Why?
|
| Motor Vehicles | 6 | 2023 | 32 | 0.270 |
Why?
|
| Adolescent | 9 | 2026 | 6377 | 0.240 |
Why?
|
| Presenteeism | 1 | 2025 | 5 | 0.240 |
Why?
|
| Wakefulness | 1 | 2026 | 44 | 0.230 |
Why?
|
| Bacteriuria | 1 | 2025 | 16 | 0.230 |
Why?
|
| Urinalysis | 1 | 2025 | 37 | 0.230 |
Why?
|
| Sleep | 2 | 2026 | 240 | 0.230 |
Why?
|
| Basolateral Nuclear Complex | 1 | 2025 | 8 | 0.230 |
Why?
|
| Gene-Environment Interaction | 1 | 2025 | 51 | 0.230 |
Why?
|
| Galvanic Skin Response | 1 | 2025 | 25 | 0.230 |
Why?
|
| Autonomic Nervous System | 1 | 2025 | 36 | 0.230 |
Why?
|
| Prognosis | 3 | 2025 | 1793 | 0.220 |
Why?
|
| Equol | 1 | 2024 | 5 | 0.220 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2025 | 47 | 0.220 |
Why?
|
| ROC Curve | 3 | 2021 | 295 | 0.220 |
Why?
|
| Binge Drinking | 1 | 2025 | 38 | 0.220 |
Why?
|
| Mouth | 1 | 2024 | 35 | 0.220 |
Why?
|
| Animals | 8 | 2025 | 21533 | 0.220 |
Why?
|
| Metabolomics | 1 | 2024 | 60 | 0.210 |
Why?
|
| Mobile Applications | 1 | 2026 | 140 | 0.210 |
Why?
|
| Pollination | 1 | 2023 | 3 | 0.210 |
Why?
|
| Flowers | 1 | 2023 | 6 | 0.210 |
Why?
|
| Income | 1 | 2025 | 175 | 0.210 |
Why?
|
| Estradiol | 1 | 2025 | 262 | 0.210 |
Why?
|
| Massachusetts | 3 | 2024 | 2149 | 0.200 |
Why?
|
| Plants | 1 | 2023 | 50 | 0.200 |
Why?
|
| Symbiosis | 1 | 2023 | 39 | 0.200 |
Why?
|
| Gray Matter | 1 | 2023 | 38 | 0.200 |
Why?
|
| Internal Capsule | 1 | 2023 | 11 | 0.200 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 938 | 0.200 |
Why?
|
| Longevity | 1 | 2024 | 119 | 0.200 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2023 | 13 | 0.200 |
Why?
|
| Computational Biology | 1 | 2025 | 364 | 0.190 |
Why?
|
| Chronic Pain | 1 | 2025 | 152 | 0.190 |
Why?
|
| Biological Availability | 1 | 2023 | 209 | 0.190 |
Why?
|
| Dreams | 1 | 2022 | 3 | 0.190 |
Why?
|
| Epigenesis, Genetic | 1 | 2026 | 406 | 0.190 |
Why?
|
| Dissociative Disorders | 1 | 2022 | 8 | 0.190 |
Why?
|
| Acute Pain | 1 | 2022 | 18 | 0.190 |
Why?
|
| Cannabis | 1 | 2023 | 54 | 0.190 |
Why?
|
| Sex Characteristics | 1 | 2024 | 212 | 0.180 |
Why?
|
| Prevalence | 3 | 2021 | 1441 | 0.180 |
Why?
|
| Phylogeny | 1 | 2023 | 395 | 0.180 |
Why?
|
| Logistic Models | 2 | 2016 | 1282 | 0.180 |
Why?
|
| Sex Factors | 3 | 2025 | 997 | 0.180 |
Why?
|
| Alcoholism | 1 | 2025 | 328 | 0.180 |
Why?
|
| Child Abuse | 1 | 2023 | 89 | 0.180 |
Why?
|
| Functional Neuroimaging | 1 | 2021 | 15 | 0.180 |
Why?
|
| Insulins | 1 | 2022 | 15 | 0.180 |
Why?
|
| Social Support | 1 | 2024 | 388 | 0.180 |
Why?
|
| Blood Pressure | 1 | 2024 | 526 | 0.180 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 167 | 0.170 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 21 | 0.170 |
Why?
|
| Human Development | 1 | 2020 | 9 | 0.170 |
Why?
|
| Abscess | 1 | 2021 | 80 | 0.170 |
Why?
|
| Health | 1 | 2020 | 31 | 0.170 |
Why?
|
| Drainage | 1 | 2021 | 155 | 0.170 |
Why?
|
| Proton Pump Inhibitors | 1 | 2021 | 47 | 0.160 |
Why?
|
| Virus Replication | 1 | 2002 | 324 | 0.160 |
Why?
|
| Diet | 1 | 2024 | 539 | 0.160 |
Why?
|
| Monocytes | 1 | 2002 | 364 | 0.160 |
Why?
|
| Sleep Wake Disorders | 1 | 2021 | 77 | 0.160 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2019 | 8 | 0.160 |
Why?
|
| Models, Theoretical | 1 | 2021 | 274 | 0.160 |
Why?
|
| United States | 6 | 2026 | 8131 | 0.150 |
Why?
|
| Psychometrics | 1 | 2021 | 393 | 0.150 |
Why?
|
| Anxiety | 4 | 2023 | 438 | 0.150 |
Why?
|
| Self Care | 1 | 2021 | 215 | 0.150 |
Why?
|
| Occupational Diseases | 1 | 2021 | 270 | 0.150 |
Why?
|
| Ambulatory Care | 1 | 2021 | 320 | 0.140 |
Why?
|
| Intestines | 1 | 2019 | 176 | 0.140 |
Why?
|
| Paracentesis | 1 | 2016 | 12 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 2700 | 0.130 |
Why?
|
| HIV-1 | 1 | 2002 | 727 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 2294 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2019 | 419 | 0.120 |
Why?
|
| Homeostasis | 1 | 2019 | 376 | 0.120 |
Why?
|
| Multicenter Studies as Topic | 1 | 2016 | 155 | 0.120 |
Why?
|
| Age Distribution | 1 | 2016 | 259 | 0.120 |
Why?
|
| Telemedicine | 1 | 2021 | 361 | 0.120 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 416 | 0.120 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 749 | 0.120 |
Why?
|
| Recurrence | 1 | 2017 | 661 | 0.120 |
Why?
|
| Dementia | 1 | 2019 | 273 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 1172 | 0.110 |
Why?
|
| HIV Infections | 1 | 2002 | 965 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 525 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2023 | 1156 | 0.110 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2014 | 9 | 0.110 |
Why?
|
| Algorithms | 1 | 2020 | 1049 | 0.110 |
Why?
|
| Virulence | 1 | 2014 | 199 | 0.110 |
Why?
|
| Antibody Formation | 1 | 2014 | 112 | 0.100 |
Why?
|
| HLA-DR3 Antigen | 1 | 2013 | 7 | 0.100 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2014 | 127 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2021 | 824 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 302 | 0.100 |
Why?
|
| Femoral Nerve | 1 | 2013 | 10 | 0.100 |
Why?
|
| Administration, Oral | 1 | 2014 | 376 | 0.100 |
Why?
|
| Morphine | 1 | 2013 | 62 | 0.100 |
Why?
|
| Psychopathology | 2 | 2023 | 22 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 214 | 0.090 |
Why?
|
| Escherichia coli | 1 | 2017 | 728 | 0.090 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2013 | 185 | 0.090 |
Why?
|
| Influenza Vaccines | 1 | 2013 | 101 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2014 | 764 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 218 | 0.090 |
Why?
|
| Nerve Block | 1 | 2013 | 58 | 0.090 |
Why?
|
| Hip Fractures | 1 | 2013 | 77 | 0.090 |
Why?
|
| Trauma Centers | 1 | 2012 | 132 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 612 | 0.090 |
Why?
|
| Age Factors | 1 | 2015 | 1592 | 0.090 |
Why?
|
| Pain Management | 1 | 2013 | 171 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2021 | 6884 | 0.080 |
Why?
|
| Anxiety Disorders | 2 | 2023 | 201 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 998 | 0.080 |
Why?
|
| Neuroimaging | 2 | 2022 | 159 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2021 | 5822 | 0.080 |
Why?
|
| Emergency Medical Services | 1 | 2013 | 272 | 0.080 |
Why?
|
| Disease Progression | 1 | 2014 | 1218 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 645 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1114 | 0.080 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 443 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2023 | 1451 | 0.070 |
Why?
|
| Paecilomyces | 1 | 2008 | 2 | 0.070 |
Why?
|
| Bursitis | 1 | 2008 | 18 | 0.070 |
Why?
|
| Mycoses | 1 | 2008 | 71 | 0.070 |
Why?
|
| Mutation | 1 | 2014 | 2688 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 1308 | 0.060 |
Why?
|
| Child | 3 | 2022 | 4681 | 0.060 |
Why?
|
| Multifactorial Inheritance | 1 | 2025 | 28 | 0.060 |
Why?
|
| Ultrasonography | 2 | 2021 | 495 | 0.060 |
Why?
|
| Reflex, Startle | 1 | 2025 | 8 | 0.060 |
Why?
|
| Interleukin-10 | 1 | 2026 | 164 | 0.060 |
Why?
|
| Vaccines, Combined | 1 | 2023 | 9 | 0.050 |
Why?
|
| Hypothalamus | 1 | 2024 | 134 | 0.050 |
Why?
|
| Hydroxy Acids | 1 | 2023 | 2 | 0.050 |
Why?
|
| Bacteroides fragilis | 1 | 2023 | 5 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 631 | 0.050 |
Why?
|
| Bacteroides | 1 | 2023 | 9 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2023 | 43 | 0.050 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 537 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2026 | 623 | 0.050 |
Why?
|
| Anisotropy | 1 | 2023 | 63 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 36 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2023 | 53 | 0.050 |
Why?
|
| Gyrus Cinguli | 1 | 2023 | 59 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 410 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2024 | 271 | 0.050 |
Why?
|
| Nerve Net | 1 | 2023 | 101 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2025 | 800 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2002 | 103 | 0.050 |
Why?
|
| Mice | 3 | 2023 | 11209 | 0.050 |
Why?
|
| Hippocampus | 1 | 2024 | 280 | 0.050 |
Why?
|
| Biological Variation, Individual | 1 | 2021 | 3 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2022 | 29 | 0.050 |
Why?
|
| Precipitating Factors | 1 | 2021 | 3 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2023 | 117 | 0.040 |
Why?
|
| Psychophysiology | 1 | 2021 | 7 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 43 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2023 | 460 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2021 | 34 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2022 | 85 | 0.040 |
Why?
|
| Comorbidity | 1 | 2025 | 1126 | 0.040 |
Why?
|
| Rats | 1 | 2025 | 2018 | 0.040 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 51 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2021 | 20 | 0.040 |
Why?
|
| Life Change Events | 1 | 2021 | 66 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 461 | 0.040 |
Why?
|
| Self Report | 1 | 2023 | 393 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2021 | 393 | 0.040 |
Why?
|
| Microglia | 1 | 2023 | 253 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2021 | 524 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 378 | 0.040 |
Why?
|
| Emotions | 1 | 2022 | 229 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 120 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2021 | 390 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2023 | 1587 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 2782 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2101 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 43 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2013 | 22 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2013 | 239 | 0.020 |
Why?
|
| New England | 1 | 2013 | 271 | 0.020 |
Why?
|
| Analgesia | 1 | 2013 | 35 | 0.020 |
Why?
|
| Viral Load | 1 | 2013 | 228 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 185 | 0.020 |
Why?
|
| Veterans | 1 | 2019 | 799 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2013 | 531 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1718 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Fungal | 1 | 2008 | 4 | 0.020 |
Why?
|
| Ketoconazole | 1 | 2008 | 11 | 0.020 |
Why?
|
| Lung | 1 | 2013 | 972 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 2077 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2008 | 109 | 0.020 |
Why?
|